SIRT3 and breast carcinoma: The significance of Sirt3 in breast cancer cells lies in the fact that only 23% of normal breast tissue shows to be negative for Sirt3 expression, whereas even up to 72% of in situ breast lesions and 74% of invasive lesions are negative for the expression of Sirt3 [14].